Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Are The Market Size Estimates For The Cancer Supportive Care Drugs Market?

The market size for cancer supportive care drugs has experienced consistent expansion in the last few years with a expected growth from $20.83 billion in 2024 to $21.54 billion in 2025, representing a compound annual growth rate (CAGR) of 3.4%. This growth during the historic period can be credited to factors such as the expanding elderly population, the rise in chemotherapy prevalence, an increased demand for antiemetics, growing preference for online pharmacies and drug stores, a higher awareness of supportive care, increased embracing of personalized medicine and a stronger focus on palliative care.

The market for drugs supporting cancer care is projected to expand consistently over the next few years. It is predicted to reach “$25.07 billion in 2029”, growing at a compound annual growth rate (CAGR) of 3.9%. The anticipated growth in this period can be tied to the increasing knowledge about the negative side effects of cancer therapies, a rise in breast cancer cases amongst women, the provision of specific drug treatment schemes, the need for virtual doctor consultations, better pharmaceutical supply chain management, and a growing number of cancer survivors. Key trends identified for the projected period include progress in targeted treatments, the merging of biobehavioral strategies, the establishment of survivorship care programs, the inclusion of nutritional aid, advancements in strategies to manage pain, and the establishment of platforms to monitor symptoms.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15749&type=smp

What External And Internal Drivers Are Influencing The Cancer Supportive Care Drugs Market?

The growth of the cancer supportive care drugs market is predicted to be fuelled by the rising survival rates of cancer patients. The term cancer survival rate relates to the proportion of individuals living past a specific type of cancer for a particular duration, usually five years, after diagnosis. Early detection, healthcare advancements, availability of quality healthcare, the patient’s overall well-being, the cancer’s type and phase, and social and economic elements primarily determine survival rates. These drugs used in cancer supportive care play a critical role in enhancing survival rates by managing side effects like pain, nausea and anemia. This improves patient tolerance for treatments, ensuring completion of the entire therapy course, which results in better patient outcomes. For example, the US-based National Cancer Institute predicted in January 2022 that the number of cancer survivors will surge by 24.4% over the coming decade, hitting 22.5 million by 2032. Hence, the rising survival rate of cancer patients is powering the growth of the cancer supportive care drugs market.

How Is The Cancer Supportive Care Drugs Market Categorized Across Applications And Types?

The cancer supportive care drugs market covered in this report is segmented –

1) By Type: Erythropoiesis Stimulating Agents, Granulocyte Colony Stimulating Factors, Antiemetics, Bisphosphonates, Opioids, Nonsteroidal Anti Inflammatory Drugs, Other Types

2) By Application: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, Stomach Cancer, Other Applications

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Clinics, Other Channels

Subsegments:

1) By Erythropoiesis Stimulating Agents: Epoetin Alfa, Darbepoetin Alfa, Methoxy Polyethylene Glycol-Epoetin Beta

2) By Granulocyte Colony Stimulating Factors: Filgrastim, Pegfilgrastim, Lenograstim

3) By Antiemetics: 5-HT3 Receptor Antagonists, NK1 Receptor Antagonists, Corticosteroids

4) By Bisphosphonates: Zoledronic Acid, Pamidronate, Ibandronate

5) By Opioids: Morphine, Fentanyl, Oxycodone

6) By Nonsteroidal Anti Inflammatory Drugs (NSAIDs): Ibuprofen, Diclofenac, Celecoxib

7) By Other Types: Steroids, Anxiolytics, Appetite Stimulants

How Are Market Trends Influencing Competition In The Cancer Supportive Care Drugs Market?

Leading players in the cancer support care drugs market are focusing their efforts on combination treatments to address the complexities and challenges associated with cancer treatment. This approach involves the strategic use of two or more drugs that target different areas of cancer growth and survival, seeking to achieve more profound and enduring responses than monotherapy can offer. For example, in November 2023, Merck, a pharmaceutical firm from the US, gained approval from the Food and Drug Administration, an American federal agency, for KEYTRUDA, an anti-PD-1 treatment, to be used in conjunction with gemcitabine and cisplatin. This was for the care of patients suffering from locally advanced unresectable or metastatic biliary tract cancer (BTC). This combined approach demonstrated promising signs of bettering overall survival rates, offering a new alternative treatment for patients battling this difficult condition.

Who Are The Primary Market Leaders In The Cancer Supportive Care Drugs Market?

Major companies operating in the cancer supportive care drugs market are Pfizer Inc., Johnson & Johnson, Merck, AbbVie Inc., Bayer AG, Sanofi SA, Bristol Myers Squibb Company, AstraZeneca plc, Novartis AG, F Hoffmann-La Roche Ltd., Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Baxter International Inc., Otsuka Pharmaceutical Co. Ltd., Astellas Pharma Inc., Eisai Co. Ltd., Incyte Corporation, Exelixis Inc., Fagron Group, Heron Therapeutics Inc., Athenex Inc., Acrotech Biopharma LLC

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/cancer-supportive-care-drugs-global-market-report

What Are The Emerging Regional Trends Driving The Cancer Supportive Care Drugs Market?

North America was the largest region in the cancer supportive care drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer supportive care drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=15749&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model